Cell Therapy Reagents

About Metafora Biosystems

Metafora Biosystems is a Paris-based diagnostics company leveraging a proprietary platform combining single-cell metabolism analysis with artificial intelligence. The company has achieved commercial and regulatory milestones, most notably the national coverage recommendation in France for its flagship IVD test, METAglut™, for diagnosing the rare neurological disorder Glut1 Deficiency Syndrome (Glut1DS). Backed by significant non-dilutive grants like the EIC Accelerator funding and strategic partnerships with diagnostic leaders, Metafora is positioned to expand its AI-powered cytometry platform into broader research and clinical applications in immunology and cell therapy.

Therapeutic Areas